Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

This is a title in sentence case: Venetoclax-based regimens versus intensive chemotherapy in fit older adults with newly diagnosed acute myeloid leukemia (AML)：a multicenter, prospective, randomized phase II trial

Qiuyun Fang, Fei Li, Aijun Liao, Qingsong Yin, Lin Yang, Lianrong Xu, Junjie Ma, Junqing Xu, Hao Zhang, Jieyu Wang, Shaowei Qiu, Bingcheng LIU, Yingchang Mi, Jianxiang Wang, Hui Wei

Blood (2025) 146 (Supplement 1): 650.

https://doi.org/10.1182/blood-2025-650

Published: 2025

Journal Articles

1,200+ U2AF1 mutations reveal distinct clinicobiological features of the S34/Q157 co-mutation subgroup

Yujiao Jia, Haoxu Wang, Bingqing Huang, Li Qin, Jiao Chang, Ruixue Zhang, Jinqin Liu, Hui Wei, Jianxiang Wang, Jun Shi, Qi Sun, Zhijian Xiao

Blood (2025) 146 (Supplement 1): 3499.

https://doi.org/10.1182/blood-2025-3499

Published: 2025

Journal Articles

Identifying treatment response in AML through a multi-omics classifier of malignant cell states

Yang Song, Linjie Wu, Xiaohuan Qin, Weiqian Dai, Qijun Liao, Liangyu Li, Rui Li, Peide Huang, Jing Zhao, Hui Wei, Sha Hao, Tao Cheng

Blood (2025) 146 (Supplement 1): 3487.

https://doi.org/10.1182/blood-2025-3487

Published: 2025

Journal Articles

Synergistic integration of CAR-T cell pharmacokinetics and NGS-MRD evolution enables precision risk stratification in relapsed/refractory B-cell acute lymphoblastic leukemia

Runxia Gu, Shuning Wei, Shaowei Qiu, Xiaoyuan Gong, Guangji Zhang, Benfa Gong, Qiuyun Fang, Shouyun Li, Kaiqi Liu, Dong Lin, Ying Wang, Chunlin Zhou, Bingcheng LIU, Yingchang Mi, Hui Wei, Jianxiang Wang, Ying Wang

Blood (2025) 146 (Supplement 1): 3366.

https://doi.org/10.1182/blood-2025-3366

Published: 2025

Journal Articles

Olverembatinib-mediated deep remission improves allogeneic stem cell transplantation outcome in patients with blast crisis chronic myeloid leukemia: First real-world practice report

Xiaoyu Zhang, Bingcheng LIU, Weihua Zhai, Qiaoling MA, Donglin Yang, Aiming Pang, Sizhou Feng, Mingzhe Han, Yi He, Hui Wei, Erlie Jiang

Blood (2025) 146 (Supplement 1): 1999.

https://doi.org/10.1182/blood-2025-1999

Published: 2025

Journal Articles

Research on co-mutated genes in FLT3-ITD-positive acute myeloid leukemia

Li Wan, Yujiao Jia, Yan Li, Jiao Ma, Haiwei Li, Yao Yao, Hui Wei, Jianxiang Wang, Zhijian Xiao, Yingchang Mi

Blood (2025) 146 (Supplement 1): 7027.

https://doi.org/10.1182/blood-2025-7027

Published: 2025

Journal Articles

Front-line consolidation with CAR-t therapy in newly diagnosed adult ph-negative b-acute lymphoblastic leukemia: Results from a prospective, phase 2 study

Runxia Gu, Shaowei Qiu, Wenbing Liu, Xiaoyuan Gong, Shuning Wei, Guangji Zhang, Benfa Gong, Qiuyun Fang, Shouyun Li, Kaiqi Liu, Dong Lin, Ying Wang, Chunlin Zhou, Chengcai Guo, Bingcheng LIU, Yingchang Mi, Hui Wei, Ying Wang, Jianxiang Wang

Blood (2025) 146 (Supplement 1): 1561.

https://doi.org/10.1182/blood-2025-1561

Published: 2025

Journal Articles

Molecular and clinical characteristics of NUP98 rearrangements and their therapeutic responses in 6,000 patients with hematologic malignancies

Bingqing Huang, Yujiao Jia, Haoxu Wang, Li Qin, Hui Wei, Xiaofan Zhu, Jianxiang Wang, Qi Sun, Zhijian Xiao

Blood (2025) 146 (Supplement 1): 3469.

https://doi.org/10.1182/blood-2025-3469

Published: 2025

Journal Articles

Single CAR-t infusion during front-line consolidation induces deep and sustained remission in newly diagnosed adult ph+b- ALL: A prospective phase 2 study

Runxia Gu, Shaowei Qiu, Xiaoyuan Gong, Shuning Wei, Guangji Zhang, Benfa Gong, Qiuyun Fang, Shouyun Li, Kaiqi Liu, Dong Lin, Ying Wang, Chunlin Zhou, Chengcai Guo, Bingcheng LIU, Yingchang Mi, Hui Wei, Ying Wang, Jianxiang Wang

Blood (2025) 146 (Supplement 1): 442.

https://doi.org/10.1182/blood-2025-442

Published: 2025

Journal Articles

Efficacy and safety of mini-CVD combined with venetoclax and azacitidine in acute leukemia of ambiguous lineage: A single-center retrospective study

Yan Li, Yue Shang, Kaiqi Liu, Yuntao Liu, Dong Lin, Jinsong He, Jiesi Li, Yanping Zeng, Hui Wei, Zhangsong Yan, Yingchang Mi

Blood (2025) 146 (Supplement 1): 6864.

https://doi.org/10.1182/blood-2025-6864

Published: 2025

Journal Articles

Mapping T-ALL to T Cell Differentiation Trajectory Identifies an ETP-like Subgroup Arrested at an Early Stage of T Cell Development

Heye Yu, Wenbing Liu, Junping Zhang, Leling Xie, Anli Lai, Zheng Tian, Kejing Tang, Haiyan Xing, Wang Ying, Hui Wei, Qing Rao, Runxia Gu, Min Wang, Huijun Wang, Jianxiang Wang, Shaowei Qiu

Blood (2024) 144 (Supplement 1): 1463.

https://doi.org/10.1182/blood-2024-194208

Published: 2024

Journal Articles

Similar Efficacy and Distinct Safety Profile of Nilotinib, Dasatinib and Flumatinib in Chronic Myeloid Leukemia Patients Resistant or Intolerant to 1 st Line Imatinib

Bingcheng Liu, Ying Wang, Kaiqi Liu, Yan Li, Qiuyun Fang, Yuntao Liu, Xiaoyuan Gong, Chunlin Zhou, Benfa Gong, Guangji Zhang, Shaowei Qiu, Hui Wei, Yingchang Mi, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 4533.

https://doi.org/10.1182/blood-2024-204887

Published: 2024

Journal Articles

Multiomics Characterization and Comprehensive Omics-Based Classification System in Adult Patients with B-Cell Acute Lymphoblastic Leukemia

Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi

Blood (2024) 144 (Supplement 1): 5908.

https://doi.org/10.1182/blood-2024-198988

Published: 2024

Journal Articles

Inotuzumab Ozogamicin Administration in First Remission Results in Profound and Safe Minimal Residual Disease Eradication in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia: Findings from a Phase 2, Single-Arm Trial

Blood (2024) 144 (Supplement 1): 4199.

https://doi.org/10.1182/blood-2024-200713

Published: 2024

Journal Articles

Transcriptome-Based Molecular Subtypes Improve the Classification of B Cell Acute Lymphoblastic Leukemia with JAK2 Translocation

Bingqing Huang, Yujiao Jia, Haoxu Wang, Huijun Wang, Qi Sun, Chengwen Li, Hui Wei, Yingchang Mi, Xiaofan Zhu, Jianxiang Wang, Zhijian Xiao

Blood (2024) 144 (Supplement 1): 2842.

https://doi.org/10.1182/blood-2024-194421

Published: 2024

Journal Articles

Improved MRD Clearance By Incorporating Venetoclax into Pediatric-Inspired Regimen in Newly Diagnosed Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Xiaoyuan Gong, Qiuyun Fang, Runxia Gu, Shaowei Qiu, Kaiqi Liu, Dong Lin, Chunlin Zhou, Shuning Wei, Guangji Zhang, Benfa Gong, Yuntao Liu, Yan Li, Shouyun Li, Bingcheng Liu, Wang Ying, Hui Wei, Yingchang Mi, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2812.

https://doi.org/10.1182/blood-2024-199109

Published: 2024

Journal Articles

The Chromatin Accessibility Landscape and Regulatory Network of CD34 Positive Cells in Acute Myeloid Leukemia

Wenbing Liu, Yu Liu, Anli Lai, Runxia Gu, Ying Wang, Qing Rao, Yingchang Mi, Hui Wei, Shaowei Qiu, Min Wang, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2927.

https://doi.org/10.1182/blood-2024-198599

Published: 2024

Journal Articles

The Genetic Landscape of DDX41 Gene Variants in Myeloid Neoplasms: A Large Single-Center Cohort Study from China

Li Qin, Yujiao Jia, Haoxu Wang, Xiaoxue Han, Shiqiang Qu, Huijun Wang, Qi Sun, Chengwen Li, Jigang Xiao, Hui Wei, Yingchang Mi, Jianxiang Wang, Zhijian Xiao

Blood (2024) 144 (Supplement 1): 5717.

https://doi.org/10.1182/blood-2024-199897

Published: 2024

Journal Articles

Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study

Blood (2023) 142 (Supplement 1): 827.

https://doi.org/10.1182/blood-2023-184421

Published: 2023

Journal Articles

The Impact of ZNF384 Rearranged on Antigen Editing during Treatment-Specific Selective Pressures in Adult B Cell Acute Lymphoid Leukemia

Runxia Gu, Wenbin Liu, Yihan Mei, Le Li, Chunlin Zhou, Yan Li, Yuntao Liu, Shuning Wei, Dong Lin, Kaiqi Liu, Qiuyun Fang, Xiaoyuan Gong, Benfa Gong, Shaowei Qiu, Bingcheng Liu, Yingchang Mi, Hui Wei, Ying Wang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2023-188950

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

This is a title in sentence case: Venetoclax-based regimens versus intensive chemotherapy in fit older adults with newly diagnosed acute myeloid leukemia (AML)：a multicenter, prospective, randomized phase II trial

1,200+ U2AF1 mutations reveal distinct clinicobiological features of the S34/Q157 co-mutation subgroup

Identifying treatment response in AML through a multi-omics classifier of malignant cell states

Synergistic integration of CAR-T cell pharmacokinetics and NGS-MRD evolution enables precision risk stratification in relapsed/refractory B-cell acute lymphoblastic leukemia

Olverembatinib-mediated deep remission improves allogeneic stem cell transplantation outcome in patients with blast crisis chronic myeloid leukemia: First real-world practice report

Research on co-mutated genes in FLT3-ITD-positive acute myeloid leukemia

Front-line consolidation with CAR-t therapy in newly diagnosed adult ph-negative b-acute lymphoblastic leukemia: Results from a prospective, phase 2 study

Molecular and clinical characteristics of NUP98 rearrangements and their therapeutic responses in 6,000 patients with hematologic malignancies

Single CAR-t infusion during front-line consolidation induces deep and sustained remission in newly diagnosed adult ph+b- ALL: A prospective phase 2 study

Efficacy and safety of mini-CVD combined with venetoclax and azacitidine in acute leukemia of ambiguous lineage: A single-center retrospective study

Mapping T-ALL to T Cell Differentiation Trajectory Identifies an ETP-like Subgroup Arrested at an Early Stage of T Cell Development

Similar Efficacy and Distinct Safety Profile of Nilotinib, Dasatinib and Flumatinib in Chronic Myeloid Leukemia Patients Resistant or Intolerant to 1 st Line Imatinib

Multiomics Characterization and Comprehensive Omics-Based Classification System in Adult Patients with B-Cell Acute Lymphoblastic Leukemia

Inotuzumab Ozogamicin Administration in First Remission Results in Profound and Safe Minimal Residual Disease Eradication in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia: Findings from a Phase 2, Single-Arm Trial

Transcriptome-Based Molecular Subtypes Improve the Classification of B Cell Acute Lymphoblastic Leukemia with JAK2 Translocation

Improved MRD Clearance By Incorporating Venetoclax into Pediatric-Inspired Regimen in Newly Diagnosed Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

The Chromatin Accessibility Landscape and Regulatory Network of CD34 Positive Cells in Acute Myeloid Leukemia

The Genetic Landscape of DDX41 Gene Variants in Myeloid Neoplasms: A Large Single-Center Cohort Study from China

Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study

The Impact of ZNF384 Rearranged on Antigen Editing during Treatment-Specific Selective Pressures in Adult B Cell Acute Lymphoid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only